Member Info for mazik

Though the spread is off putting new investors :-) Well positive sign is that instituitions will start holding positions on news and being listed in the Main market ...IMO

Yes full faith on NFX to be rerated having held for the last six months buying from 4.35 and averaged down till 2.75, I agree its last time it will sta sub 4...happy days ahead. IMO

Company is conducting a number of commercial discussions relating to its product pipeline. If the results come out any day this month this will be rerated and I assume SP will not stay in single figures IMO.

Is this MM's code for tomorrow, I am happy we will be sailing forward...happy days ahead

Full asking price being paid...breakout after midday

Full asking price being paid...breakout after midday

Merger in food sector brings hope for Craw's shareholders and independence will be short lived...imo

Northland expects SFX-01 to meet the safety and efficacy endpoints for both Phase 2 trials which are due to be published before or around the end of calendar 2018. Reworking our financial model for Evgen, suggests a new target price of 113p, up from 97p previously. STEM�s Phase 2 interim data is expected to highlight the fact that little of Evgen�s long-term opportunity and relative low-risk profile is presently reflected in its current market valuation.

Last week high will be reached this afternoon IMO

Dave, were u taught swear words only in your life? just logged in to find your foul language thrown on me last week :-) You need help !

"This could be the share of the year". Iain Ross, currently Redx's executive chairman, who will revert to being non-executive chairman upon Anson's joining, said, "Following the events of 2017 Lisa has been tasked by the board to lead the re-launch of the company and to take the steps necessary to build a substantial biotech company built upon an innovative science base, selectively acquiring additional assets, if appropriate." "Lisa is a consummate business professional, who brings a wealth of relevant experience from the international pharmaceutical and biotech sector. I am confident that, as CEO, she is the right person to grow this company into a very exciting and meaningful entity that has the potential to create both important new medicines for patients and generate significant value for shareholders

Thanks Leas.. Have a good weekend GLA

We cannot get the timimg right paid 21p for my 35k.., well lets see what happens by Xmas

Leas thanks for your input its really appreciated, well getting positive vibes for HVO so i have taken up 35k...GLA

Results are out and nobody has commented..how strange :-) Previous statement extract below Financial results for the year ended 31 December 2017 are expected to be in-line with market expectations, with cash as at 31 December 2017 of GBP20.3 million (2016: GBP25.7 million) which is markedly ahead of expectations.

I have to do some research as to get my toe in :-)

Well what makes u feel that way....2 posts in two weeks...

Nuformix (LSE: NFX.L), the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, notes the recent share price movement and confirms that the Company is conducting a number of commercial discussions relating to its product pipeline.

There will be renewed interest from instituitional investors now and from june..imo a great share to have in the portfolio

Positive news on SFX-01 progress will rerate EVG to Northland's valuation.. IMO SFX-01's mechanism of action is to target cancer stem cells to reverse the resistance to hormone treatment seen in ER+ breast cancer.